LNTH241220C110000
- 0.50
- 0.000.00%
Lantheus Newsroom
Lantheus Holdings' (LNTH) Radiopharmaceutical Pipeline Fuels Growth Expectations
Why Lantheus Holdings Stock Won Big on Wednesday
Top Gap Ups and Downs on Wednesday: WSM, TGT, ROKU and More
Express News | Lantheus Announces Share Repurchase Program
Lantheus Holdings Insider Sold Shares Worth $812,000, According to a Recent SEC Filing
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
US Manufacturing Index Rises To 43, Highest Since 2020
Lantheus to Present at the Jefferies London Healthcare Conference
Lantheus Holdings' (NASDAQ:LNTH) Promising Earnings May Rest On Soft Foundations
Buy Rating Reaffirmed for Lantheus Amid Discounted Valuation and Promising Growth Catalysts
TD Cowen Maintains Lantheus(LNTH.US) With Buy Rating, Cuts Target Price to $110
How Is The Market Feeling About Lantheus Holdings?
Lantheus Continues to Commend CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY's Blockbuster Status for 2025
Results: Lantheus Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
A Quick Look at Today's Ratings for Lantheus(LNTH.US), With a Forecast Between $112 to $122
Lantheus Holdings Is Maintained at Market Outperform by JMP Securities
Lantheus Holdings Analyst Ratings
Mizuho Securities Maintains Lantheus(LNTH.US) With Buy Rating
JMP Securities Maintains Lantheus(LNTH.US) With Buy Rating, Cuts Target Price to $112
Lantheus: Strong Performance and Strategic Positioning Make It a Compelling Buy Despite Adjusted Price Target